Jean-Bernard Behr
Index: Chimia 65(1-2) , 49-53, (2011)
Full Text: HTML
During the last 30 past years, more life-threatening fungal infections have appeared due to the increasing frequency of patients with weakened immune systems. Inhibition of fungal enzymes involved in the biosynthesis of sterols is considered to be a safe and effective option for antifungal therapy. However, the intensive use of sterol-biosynthesis inhibitors for years has resulted in resistance development. Consequently, the search for alternative therapeutics must be intensified. In this context, the biosynthesis of chitin, an essential component of the fungal cell wall that is absent in mammalian cells, was envisioned as a safe and selective therapeutic target. We present here recent successes in the inhibition of chitin synthase, the enzyme involved in the last step of the biosynthesis of chitin.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Nikkomycin Z
CAS:59456-70-1 |
C20H25N5O10 |
|
SabR enhances nikkomycin production via regulating the trans...
2011-01-01 [BMC Microbiol. 11 , 164, (2011)] |
|
Reshuffling of Aspergillus fumigatus cell wall components ch...
2012-03-01 [Antimicrob. Agents Chemother. 56 , 1595-1598, (2012)] |
|
Characterization of the PLP-dependent aminotransferase NikK ...
2011-11-01 [FEBS J. 278(21) , 4122-35, (2011)] |
|
Characterization of a dual specificity aryl acid adenylation...
2010-09-01 [Biopolymers 93(9) , 791-801, (2010)] |
|
Engineering of an industrial polyoxin producer for the ratio...
2012-07-01 [Metab. Eng. 14(4) , 388-93, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
